| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -33.37M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
| Period | Total return |
|---|---|
| All-time high | $44.04 (Jul 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TRAX would be worth today ›No. First Tracks Biotherapeutics, Inc. has not paid a dividend in the past 12 months.
First Tracks Biotherapeutics, Inc. stock trades on NASDAQ under the ticker symbol TRAX.
First Tracks Biotherapeutics, Inc. is part of the Healthcare sector.
First Tracks Biotherapeutics, Inc. has a market cap of 1.55B USD, based on the latest quote.
First Tracks Biotherapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
